Analysis of BPA Concentration in Serum in Women of Reproductive Age With Autoimmune Thyroid Disease
NCT ID: NCT04682340
Last Updated: 2022-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2020-12-22
2022-01-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Relationship Between Urine Iodine, Urine Bisphenol A and Autoimmune Thyroid Disease in Reproductive Women
NCT03932487
Antithyroidal Antibodies With or Without Subclinical Hypothyroidism During Pregnancy in Infertile Women
NCT04249271
Maternal Autoimmune Thyroid Disease and Fetal Thyroxin
NCT01528904
Management of Thyroid Function in Hashimoto's Thyroiditis During Pregnancy
NCT04613323
The Influence of Different Thyroid Autoantibodies on Thyroid Function and Pregnancy Outcome After Assisted Reproductive Technology
NCT04019509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hashimoto's Group
Thyroid antibody positive and hypothyroidism
Serum BPA
Serum BPA levels will be compared between women with autoimmune thyroid disease and normal women.
Graves' Group
Thyroid antibody positive and hyperthyroidism
Serum BPA
Serum BPA levels will be compared between women with autoimmune thyroid disease and normal women.
Control Group
Thyroid antibody negative and euthyroidism
Serum BPA
Serum BPA levels will be compared between women with autoimmune thyroid disease and normal women.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Serum BPA
Serum BPA levels will be compared between women with autoimmune thyroid disease and normal women.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Control group: thyroid autoantibody negative, normal thyroid function
* Women aged 18 to 45 in both the control group and experimental group
Exclusion Criteria
* Previous or planned treatment with 131I or thyroidectomy
* The use of drugs affecting the thyroid function (lithium, amiodarone, interferon a, sodium nitroprusside, sunitinib, sorafenib, iodine contrast, antibiotics / antifungals / antivirals (for at least 4 weeks prior to recruitment to the study), which do not result from the treatment of thyroid disease (levothyroxine, thyreostatic drugs, glucocorticoids)
* Active malignancy
* Other autoimmune diseases
* Other endocrine diseases
* Patients with severe liver, kidney or heart failure
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jagiellonian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karolina Zawadzka
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jagiellonian University Medical College
Krakow, Malopolska, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BPA-Thyroid
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.